medigraphic.com

2010, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2010; 48 (1)

Chronic diseases and neoplasms, a view from complex sciences and primary care

García-Vigil JL

Language: Spanish
References: 31
Page: 7-12
PDF size: 38.02 Kb.


Text Extraction

Older than 65 years has at least one chronic, degenerative or neoplasm disease (CDND). The health care cost is high, and they represent the main causes that affect the quality life. From the scope of the complexity sciences, the CDND are common problems of health but their study and solutions are complex and difficult. One strategy for preventing and treating them is to identify “the weak corner”, the causal factors or the ordering parameter as the relevant point of intervention. The evidence shows that 80% of the CDND could be preventing with primary care actions like immunizations and changing the style of life.


REFERENCES

  1. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009;374(9696):1196-1208.

  2. Abeyunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007;370(9603):1929-1938.

  3. Jayasinghe UW, Proudfoot J, Barton CA, Amoroso C, Holton C, Davies GP, et al. Quality of life of Australian chronically-ill adults: patients and practice characteristics matter. Health Qual Life Outcomes 2009;7:50. Disponible en http://www.hqlo.com/ content/7/1/50

  4. Centers for Disease Control and Prevention [sede web]. Health information for older adults. Atlanta, GA. USA: CDC, 2009 [actualizado 6 de noviembre del 2009; revisado el 2 de octubre de 2009]. Disponible en http://www.cdc.gov/Aging/info.htm.

  5. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006;368(9536):679-686.

  6. Lima MG, Barros MB, César CL, Goldbaum M, Carandina L, Ciconelli RM. Impact of chronic disease on quality of life among the elderly in the state of São Paulo, Brazil: a population-based study. Pan Am J Public Health 2009;25(4):314-321.

  7. Centro de Ciencias de la Complejidad. [sede web]. ICN, UNAM, Disponible en http://www.nucleares. unam.mx/C3/

  8. Fundación José Ortega y Gasset [sede web]. Ma-drid, España: FOG. Revista de Occidente [Internet] 2008 April; (323). Suárez JL. La complejidad y sus ciencias (presentación) y Bar-Yam Y. Complejidad y escala en las organizaciones sociales. Disponible en http://www.ortegaygasset.edu/contenidos.asp?id_i=311

  9. Cocho G. Sociedades complejas: Enfermedades complejas. En: Ruelas BE, Mansilla R, et al. coordinadores. Las ciencias de la complejidad y la innovación médica. México: UNAM/SSA/Plaza y Valdez; 2005. p. 111-132.

  10. Drummond M. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313(7052):275-283.

  11. García-Vigil JL. La farmacoeconomía y su influencia en las decisiones de nuestra salud. Ciencia, Conocimiento y Tecnología 2008;(8):11-13.

  12. Tourlouki E, Matalas AL, Panagiotakos BD. Dietary habits and cardiovascular disease risk in middle-aged and elderly populations: a review of evidence. Clin Interv Aging [Internet]. 2009;4:319-330. Disponible en: http://www.dovepress.com/ dietary-habits-and-cardiovascular-disease-risk-in-middle-aged-and-elde-peerreviewed- article-CIA

  13. Mendoza-Núñez V, Martínez-Maldonado M, Correa-Muñoz E. Implementation of an active model in Mexico four prevention and control of chronic diseases in the elderly. BMC Geriatrics [Internet] 2009;9:40. Disponible en: http://www. biomedcentral.com/1471-2318/9/40

  14. Thordarson DB. Editorial: Levels of Evidence, Evidence-Based Medicine, and Foot & Ankle International. Foot Ankle Int 2008;29(9):881-882.

  15. Treadwell JR, Tregear SJ, Reston JT, Turkelson CM. A system for rating the stability and strength of medical evidence. BMC Med Res Method 2006;6:52- 71. Disponible en http://www.biomedcentral.com/1471-2288/6/52

  16. Wikipedia. La enciclopedia libre. [Internet]. Nivel de evidencia. Disponible en http://es.wikipedia. org/wiki/Nivel_de_evidencia

  17. Wang C, Schmid CH, Hibberd PL, Kalish R, Roubenoff R, Rones R, et al. Tai Chi is effective in treating knee osteoarthritis: A randomized controlled trial. Arthritis Rheum 2009;61(11):1545-1553.

  18. Lichtenstein AH, Appel LJ, Brand M et al. Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114(1):82-96. Disponible en http://www.circ.ahajour nals.org/cgi/reprint/CIRCULATIONAHA.106.176158v1

  19. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcome Study. Lancet 2009;374(9702):1677-1686.

  20. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368 (9548):1673- 1679.

  21. Lee JH, O’Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 2008;83(3):324-332.

  22. García-Álvarez JL, Sánchez-Tovar M, García-Vigil JL. Uso de antioxidantes para prevenir enfermedad cardiovascular. Metaanálisis de ensayos clínicos. Rev Med Inst Mex Seguro Soc 2009;47(1):7-16.

  23. Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist M, et al. Dietary supplement use and prostate cancer risk in the carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 2009;18(8):2202-2206.

  24. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, et al. Baseline characteristic and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer trial. Cancer Epidemiol Biomarkers Prev 2002;11(7):630-639.

  25. Ji BT, Wwissfeld JL, Chow WH, Huang WY, Shoen RE, Hayes RB. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2006;15 (5):897-901.

  26. Roethig HJ, Feng S, Liang Q, Liu J, Rees WA, Zedler BK. A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J Clin Pharmacol 2008;48 (5):580-591.

  27. Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and metaanalysis. Respiratory Res 2006;7(1):52. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC 1435894/?tool=pubmed

  28. Samson SI, Megard Y. Overview of vaccination policies for the elderly in Western European Countries. Aging Clin Exp Res 2009;21(3):210-215.

  29. Ogilvie I, Khoury AE, Dasbach E, Grabenstein JD, Goetghebeur M. Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions. Vaccine 2009;27(36):4891-4904.

  30. Center for Disease Control and Prevention. Bacterial coinfection in lung tissue specimens from fatal cases of 2009 pandemic influenza A(H1N1). United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009;58(38):1071-1074.

  31. Williams JB, Pang D, Delgado B, Kocherginsky M, Tretiakova M, Krausz T, et al. A model of gene environment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation. Cancer Prev Res 2009;2 (10):850-861.




2020     |     www.medigraphic.com